Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Inhibitors of histone deacetylase (HD) bear great potential as new drugs due to their ability to modulate transcription and to induce apoptosis or differentiation in cancer cells. We have described previously analogues of the complex natural HD inhibitors trapoxin B and trichostatin A with activities in the submicromolar range. Here we report structure-activity relationship analyses of further analogues of trichostatin A with respect to in vitro inhibition of maize HD-2 and their ability to induce terminal cell differentiation in Friend leukemic cells. This is the first report that shows the correlation between HD inhibitory activity and action on cancer cells on a larger series of similar compounds. Only the compounds that inhibit HD induce differentiation and/or exert antiproliferative activities in cell culture. Our studies support the use of in vitro systems as screening tools and provide structure-activity relationships that merit further investigation of this interesting target.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These inhibitors are active against class I and class II HDACs, and have the ability to induce multiple effects within cells, including cell differentiation, induction of cell cycle arrest, and suppression of tumor growth (Jung et al., 1999; Almenara et al., 2002; Richon et al., 1998; Yoshida et al., 1990a, 1990b).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Jung et al., 1999
Citations
Cites
Cell Biology: a Laboratory Handbook
Harris, A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.759 · Cited by 1,225
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dubé, I., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 771
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 694
Cellular Differentiation Regulated by Gibberellin in the Arabidopsis thaliana pickle Mutant
Ogas, J., Cheng, J.-C., Sung, Z. R., & Somerville, C. (1997) · Science · doi:10.1126/science.277.5322.91 · Cited by 344
Histones of Drosophila Embryos
Alfageme, C. R., Zweidler, A., Mahowald, A., & Cohen, L. H. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42534-9 · Cited by 336
Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide Derivatives
Suzuki, T., Ando, T., Tsuchiya, K., Fukazawa, N., Saito, A., Mariko, Y., Yamashita, T., & Nakanishi, O. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980565u · Cited by 293
Identification of Maize Histone Deacetylase HD2 as an Acidic Nucleolar Phosphoprotein
Lusser, A., Brosch, G., Loidl, A., Haas, H., & Loidl, P. (1997) · Science · doi:10.1126/science.277.5322.88 · Cited by 232
Self-citationHistone acetylation: facts and questions
Loidl, P. (1994) · Chromosoma · doi:10.1007/bf00337382 · Cited by 171
Self-citationBiochemical Methods for Analysis of Histone Deacetylases
Kölle, D., Brosch, G., Lechner, T., Lusser, A., & Loidl, P. (1998) · Methods · doi:10.1006/meth.1998.0636 · Cited by 146
Self-citationA non-isotopic assay for histone deacetylase activity
Hoffmann, K., Jung, M., Brosch, G., & Loidl, P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.9.2057 · Cited by 99
Self-citationA comparative study of histone deacetylases of plant, fungal and vertebrate cells
Lechner, T., Lusser, A., Brosch, G., Eberharter, A., Goralik-Schramel, M., & Loidl, P. (1996) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(96)00069-6 · Cited by 72
Self-citationThe BRCA2 is a histone acetyltransferase
Siddique, H., Zou, J.-P., Rao, V. N., & Reddy, E. S. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202003 · Cited by 63
Brosch, G., Lusser, A., Goralik-Schramel, M., & Loidl, P. (1996) · Biochemistry · doi:10.1021/bi961294x · Cited by 54
Self-citationNare, B., Allocco, J., Kuningas, R., Galuska, S., Myers, R. W., Bednarek, M. A., & Schmatz, D. M. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.3038 · Cited by 54
Erratum: The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1
Matilla‐Dueñas, A., Koshy, B. T., Cummings, C. J., Isobe, T., Orr, H. T., & Zoghbi, H. Y. (1998) · Nature · doi:10.1038/35908 · Cited by 7
(1994) · Experimental Cell Research · doi:10.1016/s0014-4827(84)71278-x · Cited by 1
Research works printed but not linked: 11
- Pennisi E, 1997, Science, 275, 157
- Pazin M. J., 1997, Cell, 86, 328
- Liu R. J., 1998, Nature, 391, 814
- Jung M., 1997, Bioorg. Med. Chem. Lett., 7, 1658
- Yoshida M., 1990, J. Biol. Chem, 265, 17179
- He L. Z., 1998, Nature Genet., 18, 135
- Lea M. A., 1995, Anticancer Res., 15, 884
- Warrell, 1999, J. Natl. Cancer Inst., 90, 1625
- Hagmann W. K., 1996, Annu. Rep. Med. Chem., 31, 240
- Richon V. M., 1999, 90th Annual Meeting of the AACR, Apr 10−14
- Schmidt K., 1999, Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. Arch. Pharm. Pharm. Med. Chem
Cited by
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
“…San Diego, California 92121. multiple effects within cells, including cell differentiation, induction of cell cycle arrest, and suppression of tumor and encompass the residues that form the enzyme’s growth (Jung et al., 1999; Almenara et al., 2002; Richon active site and catalytic machinery.”
BackgroundGrozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Metadata
- Authors
- Jung, M., Brosch, G., Kölle, D., Scherf, H., Gerhäuser, C., & Loidl, P.
- Affiliations
- German Cancer Research Center (DE)
- Corresponding author
- Jung, Manfred
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-10-15
- Volume
- 42
- Issue
- 22
- Pages
- 4669-4679
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2071513872
- Cited by
- 176
- References
- 18
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 5 · 2013: 6 · 2012: 4
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- histone deacetylase inhibitors, amide derivatives, structure-activity relationship, Friend leukemia cells, antiproliferative activity, anticancer drug discovery
- MeSH terms
- Animals, Cell Differentiation, Enzyme Inhibitors, Histone Deacetylases, Hydroxamic Acids, Models, Molecular, Structure-Activity Relationship, Tumor Cells, Cultured, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.